Paperpal Prime Logo

Blood advances : Impact Factor & More

eISSN: 2473-9537pISSN: 2473-9529

Key Metrics

CiteScore
9.6
Eigenfactor
0.01 - 0.05
H-Index
69
Impact Factor
5 - 10
Scite Index
0.89 5-Year SI
SJR
Q1Hematology
SNIP
1.95
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Blood advances

Blood advances Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher ELSEVIER
Language English
Frequency Semi-monthly
General Details
LanguageEnglish
FrequencySemi-monthly
Publication Start Year2016
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Blood advances ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Blood advances

A dynamic prognostic model for polycythemia vera long-term outcomes in patients treated with ruxolitinib.
  • 11 Aug 2026
  • Blood advances
Wang L, Wang J, Li J, Coller BS. A monoclonal antibody to platelet αIIbβ3 that inhibits protein disulfide isomerase binding and platelet aggregation. Blood Adv. 2026;10(9):3172-3185.
  • 11 Aug 2026
  • Blood advances
Impact of fludarabine exposure on CAR T-cell outcomes in patients with large B-cell lymphoma.
  • 11 Aug 2026
  • Blood advances
Inhibition of human FcγRIII prevents platelet destruction in a dual-humanized murine model of FNAIT.
  • 11 Aug 2026
  • Blood advances
Effect of PCC on thrombin generation in patients on FXaI with bleeding or needing urgent surgery (GAUGE).
  • 11 Aug 2026
  • Blood advances
Glowing evidence: radiation shines in early NLPHL.
  • 11 Aug 2026
  • Blood advances
A dynamic prognostic model for polycythemia vera long-term outcomes in patients treated with ruxolitinib.
  • 11 Aug 2026
  • Blood advances
Wang L, Wang J, Li J, Coller BS. A monoclonal antibody to platelet αIIbβ3 that inhibits protein disulfide isomerase binding and platelet aggregation. Blood Adv. 2026;10(9):3172-3185.
  • 11 Aug 2026
  • Blood advances
Impact of fludarabine exposure on CAR T-cell outcomes in patients with large B-cell lymphoma.
  • 11 Aug 2026
  • Blood advances
Inhibition of human FcγRIII prevents platelet destruction in a dual-humanized murine model of FNAIT.
  • 11 Aug 2026
  • Blood advances
Effect of PCC on thrombin generation in patients on FXaI with bleeding or needing urgent surgery (GAUGE).
  • 11 Aug 2026
  • Blood advances
Glowing evidence: radiation shines in early NLPHL.
  • 11 Aug 2026
  • Blood advances

FAQs on Blood advances